Common carotid artery intima-media thickness: the Cardiovascular Risk Factor Multiple Evaluation in Latin America

Pierre-Jean Touboul1, Eric Vicaut, Julien Labreuche

  • 1INSERM U-698, Department of Neurology and Stroke Center, Bichat Claude Bernard University, 46 rue Henri Huchard, Paris, France.

Insights

The CARMELA study found that common carotid artery intima-media thickness (CCAIMT) increases with age and cardiovascular risk factors in Latin American populations. Higher CCAIMT is linked to metabolic syndrome, hypertension, hypercholesterolemia, obesity, and diabetes.

Area of Science:

  • Cardiovascular epidemiology
  • Vascular biology
  • Public health

Background:

  • Common carotid artery intima-media thickness (CCAIMT) is a predictor of cardiovascular events.
  • The CARMELA study assessed CCAIMT and cardiovascular risk factors in 7 Latin American cities.
  • This research explored the relationship between CCAIMT and cardiovascular risk markers in urban Latin American populations.

Purpose of the Study:

  • To assess common carotid artery intima-media thickness (CCAIMT) in urban Latin American populations.
  • To determine the prevalence of cardiovascular risk factors in these populations.
  • To evaluate the association between CCAIMT and cardiovascular risk factors, including metabolic syndrome.

Main Methods:

  • Cross-sectional, population-based, observational study design.
  • Stratified, multistage sampling across 7 Latin American cities.
  • Carotid ultrasonography following Mannheim intima-media thickness consensus guidelines.

Main Results:

  • CCAIMT increased with age and was higher in the presence of cardiovascular risk factors.
  • A significant linear trend was observed between increasing CCAIMT and a greater number of cardiovascular risk factors (p < 0.001).
  • Metabolic syndrome, hypercholesterolemia, obesity, diabetes, and hypertension were all associated with increased CCAIMT.

Conclusions:

  • CARMELA provided normative CCAIMT values by age and sex for urban Latin Americans.
  • The study demonstrated that CCAIMT increases with cardiovascular risk factors and metabolic syndrome.
  • This highlights CCAIMT as a valuable marker for cardiovascular risk in this population.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...